SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hsiou-Ting Kuo, Shing-Lung Liu, Wen-Chieh Chiu, Chun-Jen Fang, Hsien-Chen Chang, Wei-Ren Wang, Po-An Yang, Jhe-Hao Li, Shing-Jong Huang, Shou-Ling Huang, Richard P. Cheng, Effect of charged amino acid side chain length on lateral cross-strand interactions between carboxylate- and guanidinium-containing residues in a β-hairpin, Amino Acids, 2015, 47, 5, 885

    CrossRef

  2. 2
    Y.-h. Xu, K. Xu, Y. Sun, B. Liou, B. Quinn, R.-h. Li, L. Xue, W. Zhang, K. D. R. Setchell, D. Witte, G. A. Grabowski, Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice, Human Molecular Genetics, 2014, 23, 15, 3943

    CrossRef

  3. 3
    Hsiou-Ting Kuo, Chun-Jen Fang, Hsin-Yun Tsai, Min-Fan Yang, Hsien-Chen Chang, Shing-Lung Liu, Li-Hung Kuo, Wei-Ren Wang, Po-An Yang, Shing-Jong Huang, Shou-Ling Huang, Richard P. Cheng, Effect of Charged Amino Acid Side Chain Length on Lateral Cross-Strand Interactions between Carboxylate-Containing Residues and Lysine Analogues in a β-Hairpin, Biochemistry, 2013, 52, 51, 9212

    CrossRef

  4. 4
    Inga Liepelt-Scarfone, Susanne Gräber, Monika Fruhmann Berger, Anne Feseker, Gülsüm Baysal, Ilona Csoti, Jana Godau, Alexandra Gaenslen, Heiko Huber, Karin Srulijes, Kathrin Brockmann, Daniela Berg, Cognitive Profiles in Parkinson’s Disease and Their Relation to Dementia: A Data-Driven Approach, International Journal of Alzheimer's Disease, 2012, 2012, 1

    CrossRef

  5. 5
    Kurt A Jellinger, Neurobiology of cognitive impairment in Parkinson’s disease, Expert Review of Neurotherapeutics, 2012, 12, 12, 1451

    CrossRef

  6. 6
    Kurt A. Jellinger, Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts, Movement Disorders, 2012, 27, 1
  7. 7
    Ann D. Cohen, Gil D. Rabinovici, Chester A. Mathis, William J. Jagust, William E. Klunk, Milos D. Ikonomovic, Current State of Alzheimer's Disease Research and Therapeutics, 2012,

    CrossRef

  8. 8
    Glenda M. Halliday, Yun Ju C. Song, Antony J. Harding, Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s disease, Journal of Neural Transmission, 2011, 118, 5, 713

    CrossRef

  9. 9
    Pekka Jokinen, Noora Scheinin, Sargo Aalto, Kjell Någren, Nina Savisto, Riitta Parkkola, Johanna Rokka, Merja Haaparanta, Matias Röyttä, Juha O. Rinne, [11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson’s disease with and without dementia, Parkinsonism & Related Disorders, 2010, 16, 10, 666

    CrossRef

  10. 10
    Krisztina K. Johansen, Linda R. White, Sigrid B. Sando, Jan O. Aasly, Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies, Parkinsonism & Related Disorders, 2010, 16, 5, 307

    CrossRef

  11. 11
    Kurt A. Jellinger, The neuropathologic substrate of Parkinson disease dementia, Acta Neuropathologica, 2010, 119, 1, 151

    CrossRef

  12. 12
    Ian McKeith, Commentary: DLB and PDD: the same or different? Is there a debate?, International Psychogeriatrics, 2009, 21, 02, 220

    CrossRef

  13. 13
    Inga Liepelt, Matthias Reimold, Walter Maetzler, Jana Godau, Gerald Reischl, Alexandra Gaenslen, Heinz Herbst, Daniela Berg, Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration—[18F]FDG-PET, Movement Disorders, 2009, 24, 10
  14. 14
    David J. Brooks, Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography, Movement Disorders, 2009, 24, S2
  15. 15
    Michail E. Kalaitzakis, Ronald K. B. Pearce, The morbid anatomy of dementia in Parkinson’s disease, Acta Neuropathologica, 2009, 118, 5, 587

    CrossRef

  16. 16
    Kurt A. Jellinger, The Neuropathologic Substrate of Parkinson Disease Dementia, Journal of Movement Disorders, 2009, 2, 1, 1

    CrossRef

  17. 17
    A. Johansson, I. Savitcheva, A. Forsberg, H. Engler, B. Långström, A. Nordberg, H. Askmark, [11C]-PIB imaging in patients with Parkinson's disease: Preliminary results, Parkinsonism & Related Disorders, 2008, 14, 4, 345

    CrossRef

  18. 18
    K. A. Jellinger, J. Attems, Cerebral amyloid angiopathy in Lewy body disease, Journal of Neural Transmission, 2008, 115, 3, 473

    CrossRef

  19. 19
    Lucilla Parnetti, Pietro Tiraboschi, Alessia Lanari, Maria Peducci, Chiara Padiglioni, Cataldo D'Amore, Laura Pierguidi, Nicola Tambasco, Aroldo Rossi, Paolo Calabresi, Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies, Biological Psychiatry, 2008, 64, 10, 850

    CrossRef

  20. 20
    Tammaryn Lashley, Janice L. Holton, Emma Gray, Konrad Kirkham, Sean S. O’Sullivan, Arlete Hilbig, Nicholas W. Wood, Andrew J. Lees, Tamas Revesz, Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients, Acta Neuropathologica, 2008, 115, 4, 417

    CrossRef

  21. 21
    Kurt A. Jellinger, Johannes Attems, Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease, Acta Neuropathologica, 2008, 115, 4, 427

    CrossRef

  22. You have free access to this content22
    Mariese A. Hely, Wayne G.J. Reid, Michael A. Adena, Glenda M. Halliday, John G.L. Morris, The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years, Movement Disorders, 2008, 23, 6
  23. 23
    B. Mollenhauer, M. Bibl, H. Esselmann, P. Steinacker, C. Trenkwalder, J. Wiltfang, M. Otto, Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis?, Journal of Neural Transmission, 2007, 114, 7, 919

    CrossRef

  24. 24
    Inga Liepelt, Walter Maetzler, Hans-Peter Blaicher, Thomas Gasser, Daniela Berg, Treatment of Dementia in Parkinsonian Syndromes with Cholinesterase Inhibitors, Dementia and Geriatric Cognitive Disorders, 2007, 23, 6, 351

    CrossRef

  25. 25
    Teus van Laar, Achtergronden en behandeling van Lewy body dementie, Tijdschrift voor VerpleeghuisGeneeskunde, 2006, 31, 3, 108

    CrossRef

  26. 26
    Nancy R. Barbas, Cognitive, Affective, and Psychiatric Features of Parkinson's Disease, Clinics in Geriatric Medicine, 2006, 22, 4, 773

    CrossRef

  27. 27
    Estifanos Ghebremedhin, Kelly Del Tredici, Mario Vuksic, Udo Rüb, Dietmar R Thal, Guido J Burbach, Albert Rosenberger, Heike Bickeböller, Thomas Deller, Rob A. I de Vos, Ernst N. H Jansen Steur, Heiko Braak, Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology, Journal of Neuropathology and Experimental Neurology, 2006, 65, 2, 116

    CrossRef

  28. 28
    Marta Barrachina, Esther Dalfó, Berta Puig, Noemi Vidal, Meritxell Freixes, Esther Castaño, Isidro Ferrer, Amyloid-β deposition in the cerebral cortex in Dementia with Lewy bodies is accompanied by a relative increase in AβPP mRNA isoforms containing the Kunitz protease inhibitor, Neurochemistry International, 2005, 46, 3, 253

    CrossRef

  29. 29
    Olga Pletnikova, Neva West, Michael K. Lee, Gay L. Rudow, Richard L. Skolasky, Ted M. Dawson, Laura Marsh, Juan C. Troncoso, Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases, Neurobiology of Aging, 2005, 26, 8, 1183

    CrossRef

  30. 30
    S. Papapetropoulos, A. Lieberman, J. Gonzalez, D. C. Mash, Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?, Acta Neurologica Scandinavica, 2005, 111, 6
  31. 31
    Gail A. Kang, Jeff M. Bronstein, Donna L. Masterman, Matthew Redelings, Jarrod A. Crum, Beate Ritz, Clinical characteristics in early Parkinson's disease in a central California population-based study, Movement Disorders, 2005, 20, 9
  32. 32
    Katie Wiltshire, Sheri Foster, Jeffrey A. Kaye, Brent J. Small, Richard Camicioli, Corpus Callosum in Neurodegenerative Diseases: Findings in Parkinson’s Disease, Dementia and Geriatric Cognitive Disorders, 2005, 20, 6, 345

    CrossRef

  33. 33
    Travis Dunckley, Keith D. Coon, Dietrich A. Stephan, Discovery and development of biomarkers of neurological disease, Drug Discovery Today, 2005, 10, 5, 326

    CrossRef

  34. 34
    Dag Aarsland, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  35. 35
    Keith D Coon, Travis Dunckley, Dietrich A Stephan, Biomarker identification in neurologic diseases: improving diagnostics and therapeutics, Expert Review of Molecular Diagnostics, 2004, 4, 3, 361

    CrossRef

  36. 36
    Igor Sibon, Fran??ois Tison, Vascular parkinsonism, Current Opinion in Neurology, 2004, 17, 1, 49

    CrossRef

  37. 37
    Diane D. Murphy, Bernard Ravina, Brain banking for neurodegenerative diseases, Current Opinion in Neurology, 2003, 16, 4, 459

    CrossRef

  38. 38
    Kurt A. Jellinger, Prevalence of Alzheimer lesions in Parkinson's disease, Movement Disorders, 2003, 18, 10
  39. 39
    Diane Murphy, Bernard Ravina, Current Opinion in Neurology, 2003, 16, 4, 459

    CrossRef